ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
132 hedge funds and large institutions have $382M invested in Array Biopharma Inc in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 42 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
34% less capital invested
Capital invested by funds: $578M → $382M (-$195M)
50% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 34
Holders
132
Holding in Top 10
2
Calls
$5.4M
Puts
$5.87M
Top Buyers
| 1 | +$6.42M | |
| 2 | +$5.9M | |
| 3 | +$3.83M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$3.44M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$2.64M |
Top Sellers
| 1 | -$15.5M | |
| 2 | -$10.9M | |
| 3 | -$4.64M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$4.46M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.02M |